HOME >> MEDICINE >> NEWS
Cholesterol in stroke patients exceeds national guidelines

ST. PAUL, Minn Many stroke patients have cholesterol higher than national guidelines recommend that, if managed, may have prevented the stroke from happening, according to a study published in the February 27, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

The study of 1,040 people hospitalized for stroke or transient ischemic attack (TIA) found that 27 percent had cholesterol higher than recommended by national guidelines. TIA happens when blood flow to part of the brain is reduced for a short period of time, but then returns, resulting in temporary neurological symptoms.

"If this high cholesterol had been recognized and the guidelines been followed, then 93 percent of these people would have been treated with cholesterol-lowering drugs," said Eric E. Smith, MD, MPH, with the Massachusetts General Hospital Stroke Service in Boston, and a member of the American Academy of Neurology. "Studies have shown that these drugs reduce the risk of stroke, so it's probable that, if the guidelines had been followed, at least some of these strokes and TIAs would never have happened."

Even people who had previously been diagnosed with high cholesterol and those who were already taking cholesterol-lowering drugs were not at their ideal cholesterol level according to the guidelines. Thirty percent of those previously diagnosed with high cholesterol and 19 percent of those taking cholesterol drugs were not at their ideal cholesterol level. The ideal cholesterol level is determined based on an individual's risk of stroke or heart disease.

"Unfortunately, we found that the people who were at the greatest risk for a stroke or heart attack were also the least likely to be at the guideline-recommended cholesterol levels," Smith said.

The results indicate that cholesterol levels should be tested in anyone hospitalized with a stroke or TIA, and any high levels should be treated, Smith said. "W
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
26-Feb-2007


Page: 1 2

Related medicine news :

1. Cholesterol-lowering drugs reduce risk of stroke, heart attack
2. Cholesterol-lowering drugs may be useful in an influenza pandemic
3. Cholesterol-lowering drugs not associated with increased breast cancer risk
4. Cholesterol levels discounted as a biological marker for suicide risk among alcoholics
5. Cholesterol treatment, including statins, may slow Alzheimers disease progression
6. Cholesterol levels and use of lipid-lowering drugs are not associated with breast cancer risk
7. Study, meta-analysis examine factors associated with death from heatstroke
8. Women with migraines and visual symptoms may have higher stroke risk
9. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
10. Trial stops after stroke and mortality significantly reduced by blood
11. Future therapies for stroke may block cell death

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cholesterol stroke patients exceeds national guidelines

(Date:12/22/2014)... Angeles, CA (PRWEB) December 22, 2014 ... reputable PALS, BLS and ACLS online certification provider, are ... http://www.acls-pals-bls.com . The updated site now features a ... easier than ever to use. , As a ... peoples’ information is now consolidated into a single page ...
(Date:12/22/2014)... U.S. and state health officials are investigating a listeria ... least four people and sickened 28 others in 10 ... prepackaged caramel apples until more information becomes available, the ... a news release. As of Dec. 18, a ... outbreak strains of the bacteria Listeria monocytogenes . ...
(Date:12/22/2014)... 22, 2014 Super Saturday, the last ... year as the busiest day in the 2014 holiday ... Grass Station had a steady pre-Christmas stream of customers, ... past Saturday. , “I definitely intend to take advantage…of ... Denver resident who was enjoying The Grass Station’s holiday ...
(Date:12/22/2014)... recognition of Veteran’s Day, Discount Labels contributed a portion ... that provides services to veterans and their families, free ... hundred acres in the hills of Southern Indiana, the ... hiking, horseback riding, 4-wheeling, skeet shooting, and much more. ... U.S. Service men and women, police officers, fire fighters ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 7,178 small ... bustle of Black Friday shopping and opted instead to ... marketing education company, for their 5th annual “Black Friday ... charged just $7 to attend the 5 hour online ... they promptly donated to support two Central Texas based ...
Breaking Medicine News(10 mins):Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3
(Date:12/22/2014)... Pa. and STOCKHOLM , ... (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced ... (CHMP) of the European Medicines Agency (EMA) has adopted ... clostridium histolyticum) for the treatment of adult men with ... of at least 30 degrees at the start of ...
(Date:12/22/2014)... Calif. , Dec, 22, 2014  Eiger ... Phase 2a study of lonafarnib in patients with ... was conducted at the National Institutes of Health ... .  The double-blinded, randomized, placebo-controlled, dose ascending ... twice daily and 200 mg twice daily for ...
(Date:12/22/2014)... 22, 2014 TWi Biotechnology, Inc., today ... for AC-201, TWi Biotechnology,s lead drug candidate, from ... China for patent application numbered 201180018154.8.  ... salts, active metabolite for treatment of type II ... treatment using AC-201 for type II diabetes, and ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
Cached News: